All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 22 points (0.1%) at 17,547 as of Wednesday, Dec. 16, 2015, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,993 issues advancing vs. 1,000 declining with 129 unchanged.

The Financial sector currently sits up 0.4% versus the S&P 500, which is up 0.3%. Top gainers within the sector include Nomura Holdings ( NMR), up 3.0%, Orix ( IX), up 2.2%, Equifax ( EFX), up 2.1%, Western Union ( WU), up 1.9% and Simon Property Group ( SPG), up 1.9%. On the negative front, top decliners within the sector include BlackRock ( BLK), down 1.6%, American International Group ( AIG), down 0.7% and Charles Schwab ( SCHW), down 0.6%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3. Marsh & McLennan Companies ( MMC) is one of the companies pushing the Financial sector higher today. As of noon trading, Marsh & McLennan Companies is up $0.51 (0.9%) to $56.93 on average volume. Thus far, 893,170 shares of Marsh & McLennan Companies exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $56.69-$57.13 after having opened the day at $56.80 as compared to the previous trading day's close of $56.42.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions primarily in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services; and Consulting. Marsh & McLennan Companies has a market cap of $28.7 billion and is part of the insurance industry. Shares are down 1.4% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts who rate Marsh & McLennan Companies a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Marsh & McLennan Companies as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, notable return on equity and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Marsh & McLennan Companies Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, HCP ( HCP) is up $0.42 (1.2%) to $36.68 on light volume. Thus far, 1.2 million shares of HCP exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $36.34-$36.84 after having opened the day at $36.40 as compared to the previous trading day's close of $36.25.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. HCP has a market cap of $16.7 billion and is part of the real estate industry. Shares are down 17.7% year-to-date as of the close of trading on Tuesday. Currently there are 3 analysts who rate HCP a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates HCP as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company's earnings per share and deteriorating net income. Get the full HCP Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, MetLife ( MET) is up $0.37 (0.8%) to $47.94 on light volume. Thus far, 2.0 million shares of MetLife exchanged hands as compared to its average daily volume of 6.1 million shares. The stock has ranged in price between $47.90-$48.41 after having opened the day at $48.10 as compared to the previous trading day's close of $47.57.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. MetLife has a market cap of $51.6 billion and is part of the insurance industry. Shares are down 12.1% year-to-date as of the close of trading on Tuesday. Currently there are 9 analysts who rate MetLife a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates MetLife as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full MetLife Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the financial sector could consider Financial Select Sector SPDR ( XLF) while those bearish on the financial sector could consider Proshares Short Financials ( SEF).